Skip to content

Validation of the Diagnostic Performance of the Sleep Apnea Syndrome by the Withings HWA09 Device

Validation of the Diagnostic Performance of the Sleep Apnea Syndrome by the Withings HWA09 Device

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04496843
Acronym
VPASH
Enrollment
220
Registered
2020-08-03
Start date
2020-01-16
Completion date
2026-12-31
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea

Brief summary

Sleep Apnea Syndrome (SAS) is a common pathology affecting between 4 and 8% of the general population. It aggravates morbidity and cardio-metabolic mortality and is responsible for accidents related to vigilance disorders. It is estimated that 80%% of SAS cases are not diagnosed and therefore not treated. It is however impracticable to propose a diagnostic test of polygraphy (PG) or polysomnography (PSG) to every patient because of the cost and insufficient availability of these exams. It would therefore be useful to carry out a screening test before directing the patient to a complete test. Several simplified polygraph systems with 2 or 3 channels have been proposed (nasal cannula, oximetry, heart rate) but they generally record only one night and remain intrusive enough to perturb the sleep. The Withings HWA09 is a wrist-worn watch, which allows screening of SAS from four signals: movement, heart rate, breathing rate and blood oxygen saturation (SpO2). The objective of the present study is to validate the diagnostic performance of the Withings HWA09 for the detection of SAS compared to PSG.

Detailed description

Subjects are patients having a prescription for a one-night polysomnographic consultation in order to diagnose potential sleep disorders. The investigator will collect the consent before including any patient in this study. The study last one night per patient, during which saturation signal recordings and the sleep apnea detection will be made by the HWA09 watch, in comparison to the polysomnography.

Interventions

DIAGNOSTIC_TESTHWA09 Measurement

Simultaneous recording of Withings HWA09 Device and PSG devices for the reference.

Sponsors

Withings
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years

Inclusion criteria

* Adults, men and women, between 18 and 70 y/o * Patient addressed for a polysomnography because of a suspicion of sleep respiratory disorders * Subject having expressed his/her consent to take part in the study

Exclusion criteria

* Recording under continuous positive pressure * Subject having refuse to give his/her consent * Vulnerable subjects according to regulation in force : * Pregnant, parturient or breastfeeding women * Subjects having a known allergy to one of the components of the sensor (silicon, stainless steel, sapphire glass) * Subjects deprived of liberty by a court, medical or administrative order * Subjects legally protected or unable to express their non-opposition to take part in the study * Subjects unable to express their consent due to linguistic or mental incapacities

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and Specificity of Withings HWA09 at AHI threshold value of 5/h in PSG1 yearSensitivity and specificity for SAS detection by Withings HWA09 compared to PSG at apnea-hypopnea index (AHI) threshold value of 5/h in PSG.
Sensitivity and Specificity of Withings HWA09 at AHI threshold value of 15/h in PSG1 yearSensitivity and specificity for SAS detection by Withings HWA09 compared to PSG at AHI threshold value of 15/h in PSG.
Sensitivity and Specificity of Withings HWA09 at AHI threshold value of 30/h in PSG1 yearSensitivity and specificity for SAS detection by Withings HWA09 compared to PSG at AHI threshold value of 30/h in PSG.

Secondary

MeasureTime frameDescription
Sensitivity and Specificity of the desaturation detected by Withings HWA091 yearSensitivity and specificity of the desaturation detection by Withings HWA09 compared to an oximeter with the Oxygen Desaturation Index (ODI)
Accuracy of Withings HWA09 to estimate total sleep time (TST) given by PSG1 yearBias and mean absolute error (MAE)
Impact of the proportion of apnea events on the performance of Withings HWA091 yearBias and MAE for apnea index (AI) estimated by Withings HWA09 compared to PSG results
Impact of the proportion of hypopnea events on the performance of Withings HWA091 yearBias and MAE for hypopnea index (HI) estimated by Withings HWA09 compared to PSG results
Influence of the position of the sleeper (supine vs prone/lateral decubitus position) on the error of the AHI predicted by Withings HWA09 compared with PSG1 yearAverage difference of AHI between Withings HWA09 and the PSG in each position
Reliability of Withings HWA091 yearRate of unusable of lost nights

Countries

Belgium, France

Contacts

PRINCIPAL_INVESTIGATORGabriel Roisman

Antoine Béclère Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026